Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(-20.0%)
AUD 0.0
(-20.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.58 Million AUD | -49.78% |
| 2022 | -3.06 Million AUD | 32.67% |
| 2021 | -4.55 Million AUD | -34.34% |
| 2020 | -3.38 Million AUD | -676.76% |
| 2019 | 587.32 Thousand AUD | 111.8% |
| 2018 | -4.97 Million AUD | 49.16% |
| 2017 | -9.78 Million AUD | 18.64% |
| 2016 | -12.03 Million AUD | 14.76% |
| 2015 | -14.11 Million AUD | -11.15% |
| 2014 | -12.69 Million AUD | 29.19% |
| 2013 | -17.93 Million AUD | -14.07% |
| 2012 | -15.72 Million AUD | -18.6% |
| 2011 | -13.25 Million AUD | -437.36% |
| 2010 | 3.92 Million AUD | 141.97% |
| 2009 | -9.36 Million AUD | -110.09% |
| 2008 | 92.74 Million AUD | 881.95% |
| 2007 | -11.86 Million AUD | -35.52% |
| 2006 | -8.75 Million AUD | -126.33% |
| 2005 | -3.86 Million AUD | -119.9% |
| 2004 | -1.75 Million AUD | -74.47% |
| 2003 | -1 Million AUD | -352.51% |
| 2002 | -222.73 Thousand AUD | 79.33% |
| 2001 | -1.07 Million AUD | 54.1% |
| 2000 | -2.34 Million AUD | -333.13% |
| 1999 | 1 Million AUD | 113.04% |
| 1998 | -7.72 Million AUD | 83.25% |
| 1997 | -46.1 Million AUD | -585.22% |
| 1996 | -6.72 Million AUD | -117.54% |
| 1995 | 38.36 Million AUD | 3629.35% |
| 1994 | -1.08 Million AUD | -146.69% |
| 1993 | 2.32 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.89 Million AUD | 0.0% |
| 2023 Q2 | -2.52 Million AUD | 0.0% |
| 2023 FY | -4.58 Million AUD | -49.78% |
| 2023 Q4 | -2.06 Million AUD | 0.0% |
| 2022 Q4 | -1.98 Million AUD | 0.0% |
| 2022 Q2 | -1.08 Million AUD | 0.0% |
| 2022 FY | -3.06 Million AUD | 32.67% |
| 2021 Q2 | -2.18 Million AUD | 0.0% |
| 2021 Q4 | -2.36 Million AUD | 0.0% |
| 2021 FY | -4.55 Million AUD | -34.34% |
| 2020 Q4 | -1.91 Million AUD | 0.0% |
| 2020 FY | -3.38 Million AUD | -676.76% |
| 2020 Q2 | -1.47 Million AUD | 0.0% |
| 2019 Q2 | 2.05 Million AUD | 0.0% |
| 2019 Q4 | -1.46 Million AUD | 0.0% |
| 2019 FY | 587.32 Thousand AUD | 111.8% |
| 2018 FY | -4.97 Million AUD | 49.16% |
| 2018 Q2 | -2.62 Million AUD | 0.0% |
| 2018 Q4 | -2.34 Million AUD | 0.0% |
| 2017 FY | -9.78 Million AUD | 18.64% |
| 2017 Q2 | -4.75 Million AUD | 0.0% |
| 2016 FY | -12.03 Million AUD | 14.76% |
| 2016 Q4 | -5.58 Million AUD | 0.0% |
| 2016 Q2 | -6.44 Million AUD | 0.0% |
| 2015 FY | -14.11 Million AUD | -11.15% |
| 2015 Q4 | -7.36 Million AUD | 0.0% |
| 2015 Q2 | -6.74 Million AUD | 0.0% |
| 2014 Q4 | -7.05 Million AUD | -215.7% |
| 2014 Q1 | -2.23 Million AUD | 0.0% |
| 2014 Q2 | -5.51 Million AUD | -146.94% |
| 2014 FY | -12.69 Million AUD | 29.19% |
| 2014 Q3 | -2.23 Million AUD | 59.5% |
| 2013 Q3 | -3.16 Million AUD | 61.98% |
| 2013 Q4 | -2.23 Million AUD | 29.5% |
| 2013 FY | -17.93 Million AUD | -14.07% |
| 2013 Q1 | -3.16 Million AUD | 0.0% |
| 2013 Q2 | -8.33 Million AUD | -163.02% |
| 2012 Q2 | -2.76 Million AUD | 0.0% |
| 2012 Q1 | -2.76 Million AUD | 0.0% |
| 2012 Q4 | -3.16 Million AUD | -14.64% |
| 2012 FY | -15.72 Million AUD | -18.6% |
| 2012 Q3 | -2.76 Million AUD | 0.0% |
| 2011 Q4 | -2.76 Million AUD | 13.12% |
| 2011 Q3 | -3.18 Million AUD | 0.0% |
| 2011 Q2 | -3.18 Million AUD | 0.0% |
| 2011 FY | -13.25 Million AUD | -437.36% |
| 2011 Q1 | -3.18 Million AUD | 0.0% |
| 2010 FY | 3.92 Million AUD | 141.97% |
| 2010 Q3 | -3.39 Million AUD | 0.0% |
| 2010 Q4 | -3.18 Million AUD | 6.26% |
| 2010 Q1 | -3.39 Million AUD | 0.0% |
| 2010 Q2 | -3.39 Million AUD | 0.0% |
| 2009 Q2 | -2.12 Million AUD | 0.0% |
| 2009 Q4 | -3.39 Million AUD | -59.66% |
| 2009 Q3 | -2.12 Million AUD | 0.0% |
| 2009 FY | -9.36 Million AUD | -110.09% |
| 2009 Q1 | -2.12 Million AUD | 0.0% |
| 2008 Q1 | -27.99 Million AUD | 0.0% |
| 2008 Q2 | -27.99 Million AUD | 0.0% |
| 2008 Q3 | -27.99 Million AUD | 0.0% |
| 2008 Q4 | -2.12 Million AUD | 92.41% |
| 2008 FY | 92.74 Million AUD | 881.95% |
| 2007 Q2 | -2.21 Million AUD | 0.0% |
| 2007 FY | -11.86 Million AUD | -35.52% |
| 2007 Q1 | -2.21 Million AUD | 0.0% |
| 2007 Q3 | -2.21 Million AUD | 0.0% |
| 2007 Q4 | -27.99 Million AUD | -1166.35% |
| 2006 FY | -8.75 Million AUD | -126.33% |
| 2006 Q4 | -2.21 Million AUD | -44.39% |
| 2006 Q3 | -1.53 Million AUD | 0.0% |
| 2006 Q2 | -1.53 Million AUD | 0.0% |
| 2006 Q1 | -1.53 Million AUD | 0.0% |
| 2005 Q2 | -2.12 Million AUD | 0.0% |
| 2005 Q4 | -1.53 Million AUD | 27.88% |
| 2005 Q3 | -2.12 Million AUD | 0.0% |
| 2005 FY | -3.86 Million AUD | -119.9% |
| 2005 Q1 | -2.12 Million AUD | 0.0% |
| 2004 Q4 | -2.12 Million AUD | -388.91% |
| 2004 FY | -1.75 Million AUD | -74.47% |
| 2004 Q2 | -434.28 Thousand AUD | 0.0% |
| 2004 Q3 | -434.28 Thousand AUD | 0.0% |
| 2004 Q1 | -434.28 Thousand AUD | 0.0% |
| 2003 Q2 | -261.5 Thousand AUD | 0.0% |
| 2003 Q4 | -434.28 Thousand AUD | -66.07% |
| 2003 Q3 | -261.5 Thousand AUD | 0.0% |
| 2003 Q1 | -261.5 Thousand AUD | 0.0% |
| 2003 FY | -1 Million AUD | -352.51% |
| 2002 FY | -222.73 Thousand AUD | 79.33% |
| 2002 Q4 | -261.5 Thousand AUD | 87.97% |
| 2002 Q3 | -2.17 Million AUD | 0.0% |
| 2002 Q2 | -2.17 Million AUD | 0.0% |
| 2002 Q1 | -2.17 Million AUD | 0.0% |
| 2001 Q1 | -2.68 Million AUD | 0.0% |
| 2001 FY | -1.07 Million AUD | 54.1% |
| 2001 Q2 | -2.68 Million AUD | 0.0% |
| 2001 Q4 | -2.17 Million AUD | 18.94% |
| 2001 Q3 | -2.68 Million AUD | 0.0% |
| 2000 Q3 | -587 Thousand AUD | 0.0% |
| 2000 Q4 | -2.68 Million AUD | -356.99% |
| 2000 FY | -2.34 Million AUD | -333.13% |
| 2000 Q2 | -587 Thousand AUD | 0.0% |
| 2000 Q1 | -587 Thousand AUD | 0.0% |
| 1999 Q3 | 251.78 Thousand AUD | 0.0% |
| 1999 FY | 1 Million AUD | 113.04% |
| 1999 Q1 | 251.78 Thousand AUD | 0.0% |
| 1999 Q2 | 251.78 Thousand AUD | 0.0% |
| 1999 Q4 | -587 Thousand AUD | -333.14% |
| 1998 FY | -7.72 Million AUD | 83.25% |
| 1998 Q4 | 251.78 Thousand AUD | 113.04% |
| 1998 Q3 | -1.93 Million AUD | 0.0% |
| 1998 Q2 | -1.93 Million AUD | 0.0% |
| 1998 Q1 | -1.93 Million AUD | 0.0% |
| 1997 Q2 | -11.52 Million AUD | 0.0% |
| 1997 Q1 | -11.52 Million AUD | 0.0% |
| 1997 Q3 | -11.52 Million AUD | 0.0% |
| 1997 FY | -46.1 Million AUD | -585.22% |
| 1997 Q4 | -1.93 Million AUD | 83.25% |
| 1996 Q2 | -1.68 Million AUD | 0.0% |
| 1996 Q4 | -11.52 Million AUD | -585.22% |
| 1996 Q1 | -1.68 Million AUD | 0.0% |
| 1996 Q3 | -1.68 Million AUD | 0.0% |
| 1996 FY | -6.72 Million AUD | -117.54% |
| 1995 Q4 | -1.68 Million AUD | -117.54% |
| 1995 FY | 38.36 Million AUD | 3629.35% |
| 1995 Q1 | 9.59 Million AUD | 0.0% |
| 1995 Q2 | 9.59 Million AUD | 0.0% |
| 1995 Q3 | 9.59 Million AUD | 0.0% |
| 1994 Q3 | -271.75 Thousand AUD | 0.0% |
| 1994 FY | -1.08 Million AUD | -146.69% |
| 1994 Q1 | -271.75 Thousand AUD | 0.0% |
| 1994 Q4 | 9.59 Million AUD | 3629.35% |
| 1994 Q2 | -271.75 Thousand AUD | 0.0% |
| 1993 FY | 2.32 Million AUD | 0.0% |
| 1993 Q2 | 582 Thousand AUD | 0.0% |
| 1993 Q4 | -271.75 Thousand AUD | -146.69% |
| 1993 Q1 | 582 Thousand AUD | 0.0% |
| 1993 Q3 | 582 Thousand AUD | 0.0% |
| 1992 Q4 | 582 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 12.779% |
| Acrux Limited | -9.83 Million AUD | 53.333% |
| Actinogen Medical Limited | -12.83 Million AUD | 64.256% |
| AnteoTech Limited | -11.72 Million AUD | 60.865% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 19.079% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 36.2% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -214.516% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 76.588% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -3.711% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -49.853% |
| Biome Australia Limited | -1.91 Million AUD | -139.865% |
| Biotron Limited | -5.15 Million AUD | 10.91% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 68.781% |
| BTC Health Limited | 1.05 Million AUD | 534.876% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 62.719% |
| CSL Limited | 5.64 Billion AUD | 100.081% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 89.756% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 109.337% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 47.897% |
| Dimerix Limited | -25.05 Million AUD | 81.687% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 147.231% |
| Hexima Limited | -1 Million AUD | -354.938% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -59.692% |
| Immuron Limited | -5.8 Million AUD | 20.891% |
| Immutep Limited | -44.93 Million AUD | 89.788% |
| Imugene Limited | -140.93 Million AUD | 96.744% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -115.089% |
| Memphasys Limited | -2.7 Million AUD | -69.719% |
| Nanollose Limited | -1.24 Million AUD | -267.187% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 102.031% |
| Noxopharm Limited | -7.53 Million AUD | 39.095% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -123.149% |
| Nyrada Inc. | -4.56 Million AUD | -0.633% |
| Orthocell Limited | -11.68 Million AUD | 60.713% |
| PharmAust Limited | -6.65 Million AUD | 31.079% |
| Patrys Limited | -3.53 Million AUD | -29.669% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 92.952% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 36.539% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 36.141% |
| PYC Therapeutics Limited | -38.85 Million AUD | 88.19% |
| Race Oncology Limited | -13.38 Million AUD | 65.703% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 90.279% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 79.189% |
| Starpharma Holdings Limited | -15.15 Million AUD | 69.726% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Tissue Repair Ltd | -4.87 Million AUD | 5.881% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 22.718% |